3 -氟苄基异硫氰酸酯 | 63351-94-0

• 物质功能分类: 医药中间体
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3 -氟苄基异硫氰酸酯
• 中文别名: 3-氟苄基异硫氰酸酯；3-氟苯异硫氰酸酯
• 英文名称: 3-fluorobenzyl isothiocyanate
• 英文别名: 1-fluoro-3-(isothiocyanatomethyl)benzene
• CAS: 63351-94-0
• 化学式: C₈H₆FNS
• 分子量: 167.207
• InChiKey: CCKNPKNHNFDGND-UHFFFAOYSA-N

物化性质

• 沸点：
  138 °C
• 密度：
  1,22 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  44.4
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT-HARMFUL, KEEP COLD, LACHRYMATOR
• 危险品标志：
  Xi,T,C
• 危险类别码：
  R20/21/22
• 危险品运输编号：
  2810
• 海关编码：
  2930909090
• 安全说明：
  S26,S36/37/39
• 包装等级：
  III
• 危险类别：
  6.1
• 危险性防范说明：
  P262,P280,P301+P310,P303+P361+P353,P305+P351+P338,P310
• 危险性描述：
  H301,H311,H319,H331
• 储存条件：
  冷藏。

制备方法与用途

3-氟苄基异硫氰酸酯是一种用于医药合成的中间体，属于酯类有机化合物。

反应信息

• 作为反应物：
  描述：

  3 -氟苄基异硫氰酸酯 在 一水合肼 作用下， 以 乙醚 为溶剂， 反应 12.0h， 以87%的产率得到4-(3-fluorobenzyl)-3-thiosemicarbazide
  参考文献：
  名称：

  Novel selective thiadiazine DYRK1A inhibitor lead scaffold with human pancreatic β-cell proliferation activity

  摘要：

  The Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) is an enzyme that has been implicated as an important drug target in various therapeutic areas, including neurological disorders (Down syndrome, Alzheimer's disease), oncology, and diabetes (pancreatic beta-cell expansion). Current small molecule DYRK1A inhibitors are ATP-competitive inhibitors that bind to the kinase in an active conformation. As a result, these inhibitors are promiscuous, resulting in pharmacological side effects that limit their therapeutic applications. None are in clinical trials at this time. In order to identify a new DYRK1A inhibitor scaffold, we constructed a homology model of DYRK1A in an inactive, DFG-out conformation. Virtual screening of 2.2 million lead-like compounds from the ZINC database, followed by in vitro testing of selected 68 compounds revealed 8 hits representing 5 different chemical classes. We chose to focus on one of the hits from the computational screen, thiadiazine I which was found to inhibit DYRK1A with IC50 of 9.41 mu m (K-d = 7.3 mu M). Optimization of the hit compound 1, using structure-activity relationship (SAR) analysis and in vitro testing led to the identification of potent thiadiazine analogs with significantly improved binding as compared to the initial hit (K-d = 71-185 nM). Compound 3-5 induced human beta-cell proliferation at 5 mu M while showing selectivity for DYRK1A over DYRK1B and DYRK2 at 10 mu M. This newly developed DYRK1A inhibitor scaffold with unique kinase selectivity profiles has potential to be further optimized as novel therapeutics for diabetes. (C) 2018 Published by Elsevier Masson SAS.

  DOI：

  10.1016/j.ejmech.2018.08.007
• 作为产物：
  描述：

  3-氟苄胺 生成 3 -氟苄基异硫氰酸酯
  参考文献：
  名称：

  REITER J.; TOLDY L.; SCHAEFER I.; SZONDY E.; BORSY J.; LUKOVITS I., EUR. J. MED. CHEM.- CHIM. THER., 1980, 15, NO 1, 41-53

  摘要：

  DOI：

文献信息

• [EN] LIPID CONJUGATE PREPARED FROM SCAFFOLD MOIETY<br/>[FR] CONJUGUÉ LIPIDIQUE PRÉPARÉ À PARTIR D'UN FRAGMENT SQUELETTE
  申请人：INTEGRATED NANOTHERAPEUTICS INC

  公开号：WO2020191477A1

  公开（公告）日：2020-10-01

  The application relates to a lipid conjugate of formula M-X1-L wherein M is a molecule of interest such as a drug moiety; X1 is a linker group such as ester, ether or carbamate; and L is a lipid scaffold represented by formula (lId): -L1-[L2(H)(X2R)]n-L3-[L4(H)(X2R)]p-L5-L6 and wherein L comprises 5 to 40 carbon atoms and 0 to 2 carbon-carbon double bonds. The lipid conjugate can be formulated in a drug delivery vehicle such as a lipid nanoparticle (LNP).

  该应用涉及公式M-X1-L的脂质共轭物，其中M是感兴趣的分子，如药物基团；X1是连接基团，如酯、醚或氨基甲酸酯；L是由公式(lId)表示的脂质支架：-L1-[L2(H)(X2R)]n-L3-[L4(H)(X2R)]p-L5-L6，其中L包含5至40个碳原子和0至2个碳-碳双键。该脂质共轭物可以配制在药物传递载体中，如脂质纳米粒子（LNP）。
• [EN] DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS<br/>[FR] DIAMINO-PYRIMIDINES ET LEURS UTILISATIONS EN TANT QU'INHIBITEURS DE L'ANGIOGENESE
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2003074515A1

  公开（公告）日：2003-09-12

  Benzimidazole derivatives of formula (I) , which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such benzimidazole derivatives as well as methods of using the same in the treatment of hyperproliferative diseases. (I)

  本发明描述了公式(I)的苯并咪唑衍生物，它们作为TIE-2和/或VEGFR-2抑制剂是有用的。所描述的发明还包括制造这样的苯并咪唑衍生物的方法，以及使用它们在治疗增生性疾病中的方法。
• Heterocyclic modulators of nuclear receptors
  申请人：——

  公开号：US20030212111A1

  公开（公告）日：2003-11-13

  Compounds, compositions and methods for modulating the activity of nuclear receptors are provided. In particular, heterocyclic compounds are provided for modulating the activity of farnesoid X receptor (FXR), liver X receptor (LXR) and/or orphan nuclear receptors. In certain embodiments, the compounds are thiazolidinone derivatives.

  提供了用于调节核受体活性的化合物、组合物和方法。具体来说，提供了用于调节法尼索醇X受体（FXR）、肝X受体（LXR）和/或孤儿核受体活性的杂环化合物。在某些实施例中，这些化合物是噻唑啉酮衍生物。
• Ag(<scp>i</scp>)-Catalyzed rapid access to 2-amino-4-methylenethiazolines with potential applications in bioconjugation chemistry
  作者：Lingling Xiang、Haiting Wu、Yunshi Liang、Huiying Deng、Yiting He、Qin Xu、Jing Zhang

  DOI：10.1039/d1ob00464f

  日期：——

  was successfully applied to the synthesis of 2-amino-4-methylenethiazolines. This route features an unprecedented fast reaction rate with full conversion reached within 10 min at room temperature for aromatic isothiocyanates and excellent chemoselectivity for exocyclic products. The application of this strategy is further highlighted by the accelerated bioconjugation of propargylamine with fluorescein

  Ag()催化的异硫氰酸酯和炔丙胺的串联加成环化反应成功应用于2-氨基-4-亚甲基噻唑啉的合成。该路线具有前所未有的快速反应速率，在室温下10分钟内即可实现芳香族异硫氰酸酯的完全转化，并且对环外产物具有优异的化学选择性。该策略的应用进一步强调了在 Ag()-催化下炔丙胺与异硫氰酸荧光素 (FITC) 的加速生物共轭。
• Convenient Synthesis of 5-Arylidene-2-imino-4-thiazolidinone Derivatives Using Microwave Irradiation
  作者：Emmanuelle Braud、Manal Sarkis、Diem-Ngan Tran、Maria Dasso Lang、Christiane Garbay

  DOI：10.1055/s-0033-1341108

  日期：——

  A concise approach for the preparation of 5-arylidene-2-imino-4-thiazolidinone derivatives is described. Structurally diverse amines, isothiocyanates, aldehydes, and chloroacetyl chloride were combined under microwave irradiation to afford new 5-arylidene-2-imino-4-thiazolidinone derivatives. The one-pot synthesis involves the in situ formation of a thiourea followed by reaction with chloroacetyl chloride

  描述了一种用于制备 5-arylidene-2-imino-4-thiazolidinone 衍生物的简明方法。结构不同的胺、异硫氰酸酯、醛和氯乙酰氯在微波辐射下结合，得到新的 5-亚芳基-2-亚氨基-4-噻唑烷酮衍生物。一锅合成包括硫脲的原位形成，然后与氯乙酰氯和醛反应生成目标化合物。